Deliver Your News to the World

CybeRelease: (OTC: EXSA) Lands First Aircraft Orders


(CybeRelease, September 6, 2007) - Lake Harmony, Pa. - Exosphere Aircraft Company, Inc. (OTC PK: EXSA) announced they have begun accepting orders for the BD-22 and BD-22S light-sport aircraft specially designed by Director of Aeronautical Design Jim Bede. So far, Exosphere has two firm commitments for the BD-22 and the first reservation for the BD-22S. These initial orders total approximately $350,000.00 of expected revenue for the company.

Exosphere recently promoted their new aircraft at the NWEAA Fly-In in July. ``The Arlington Fly-In was instrumental in bringing in these initial orders and we look forward to securing additional requests as we move forward with production,’’ commented Jim Bede.

The limited edition LSA comes completely built and is designed to be the ultimate light-sport aircraft. Only twenty-two aircraft will ever be produced, each serialized with a special numbered placard, signed by Mr. Bede, and sold with a suite of limited edition accessories. The BD-22S will incorporate state-of-the-art equipment and is intended to redefine the top end of light-sport aircraft. The BD-22 is an all metal low wing aircraft with an exceptionally wide cabin and a roomy baggage compartment that will raise the industry standard to a new level. These new planes come at a time when light-sport aircraft sales are expected to exceed all other airplane sales, spurred on by new FAA regulations for light-sport aircraft.

About Exosphere Aircraft Company

Exosphere Aircraft Company is a light-sport aircraft design and manufacturing company, pioneering new and innovative airplanes for the private builder, bringing the best and most affordable light-sport planes to market. Exosphere offers the marketplace planes that meet the majority of consumer needs, finding ways to incorporate fuel efficiency, weight limitations, plane performance and current design trends.

To read the complete release, go to

CybeRelease Gainers are 3Com Corporation (Nasdaq: COMS), Salix Pharmaceuticals, Ltd. (Nasdaq: SLXP), Cardica, Inc. (Nasdaq: CRDC), Applix, Inc. (Nasdaq: APLX), Allscripts Healthcare Solutions Inc (Nasdaq: MDRX), Winn-Dixie Stores, Inc. (Nasdaq: WINN) and L.B. Foster Company (Nasdaq: FSTR).

CybeRelease Decliners are Finisar Corporation (Nasdaq: FNSR), Crocs, Inc. (Nasdaq: CROX), QLT Inc. (Nasdaq: QLTI), Sycamore Networks, Inc. (Nasdaq: SCMR), Gemstar-TV Guide International Inc. (Nasdaq: GMST), Northfield Laboratories Inc. (Nasdaq: NFLD) and OSI Systems, Inc. (Nasdaq: OSIS).

Information, opinions and analysis contained herein are based on sources believed to be reliable, but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. The opinions contained herein reflect our current judgment and are subject to change without notice. We accept no liability for any losses arising from an investor’s reliance on or use of this report. This report is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. A third party has hired and paid CybeRelease $500.00 for the publication of this report. Certain information included herein is forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning manufacturing, marketing, growth, and expansion. Such forward-looking information involves important risks and uncertainties that could affect actual results and cause them to differ materially from expectations expressed herein. We have no ownership of equity, no representation and do no trading of any kind.


This news content may be integrated into any legitimate news gathering and publishing effort. Linking is permitted.

News Release Distribution and Press Release Distribution Services Provided by WebWire.